Willingness to Participate in a COVID-19 Vaccine Trial Among Young Adults in China

preprint OA: closed
View at publisher

Abstract

Background: With the demand for rapid COVID-19 vaccine development and evaluation, this paper aimed to describe the prevalence and correlates of willingness to participate in COVID-19 vaccine trials among young adults in China. A cross-sectional survey with 1,912 Chinese university students was conducted during March 2020. Bivariate and multivariate analyses were performed to identify variables associated with vaccine trials participation willingness. Findings: The majority of participants (64.01%) indicated willingness to participate in COVID-19 vaccine trials. Major concerns included side effects (69.04%), concerns from family members (63.02%), worries about handicap or death (58.05%), and infection through the vaccine (53.03%). Willingness to participate was associated with demographic variables (females and those from lower social class being more willing), trust in the public health system (B = 0.019 [0.002, 0.035]), lower levels of COVID-19 stigma (B = -0.022 [-0.031, -0.013]), COVID-19 prosocial behaviors (B = 0.008 [0.001, 0.015]), and information sources for COVID-19, including family not being a primary source of information (B = -0.144 [-0.218, -0.071]), as well as school (B = 0.162 [0.088, 0.236]) and TV (B = 0.132 [0.056, 0.203]) being primary sources of COVID-19 information. Interpretation: COVID-19 vaccine trial willingness was high overall. Attending to needs of vulnerable groups (e.g., lower social class) may be an important ethical consideration in COVID-19 vaccine research. Addressing psychosocial and information factors, including public mistrust, stigma, altruism, and family-related factors, may be important to COVID-19 vaccine development and uptake. Funding Statement: National Institute of Mental Health (T32MH078788) and Beijing Normal University (Fighting COVID-19 Research Fund).Declaration of Interests: The authors declare no competing interests.Ethics Approval Statement: The study was approved by the Institutional Review Board (IRB) at Beijing Normal University Faculty of Psychology.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00